hif-2α glutathione

hif-2α glutathione Hypoxia inducible factor-1α drives cancer resistance to cuproptosis: Cancer Cell Frontiers | Clinical Potential of

Name: hif-2α glutathione Hypoxia inducible factor-1α drives cancer resistance to cuproptosis: Cancer Cell Frontiers | Clinical Potential of
Brand: usmivani.cz
SKU: 7474048134
Price: 23.03 USD
Availability: InStock
Rating: 4.4014 (11 reviews)

Frontiers Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases HIF 1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1: Cell Reports Recent update of natural compounds as HIF 1 inhibitors in colorectal DDDT Dove Medical Press Targeting of HIF to the von Hippel Lindau Ubiquitylation Complex by O2 Regulated Prolyl Hydroxylation Science

SKU: 7474048134 · From usmivani.cz

4.4

USD23.03 USD71.03

Pay in 4 interest-free payments of $5.76 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Store at room temperature, dry, always closed and out of reach of children

hif-2 glutathione Hypoxia inducible factor-1 drives cancer resistance to cuproptosis: Cancer Cell Frontiers | Clinical Potential of

Available from: 354

Cerebral imaging showed moderate brain atrophy in one sibling

Size exclusion chromatography of PHOX2B peptide QYNPIRTTF refolded with HLA-A*23:01, HLA-B*14:02, and HLA-C*07:02 shows formation of stable pMHC complex with HLA-A*23:01 and HLA-C*07:02, and minimal complex with HLA-B*14:02